Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco de Bree

Showing results (321-330 of 418) with videos related to

Pageof 42
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancerErnst J Postema, Pontus K E Börjesson, Wilhelmina C A M Buijs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 28, 2019
Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: which groups specifically benefit? Secondary analyses of a randomized controlled trialFemke Jansen, Birgit I Lissenberg-Witte, Anna M H Krebber, et al.
Oral Oncology|March 9, 2019
Elective neck dissection in oral squamous cell carcinoma: Past, present and futureRemco de Bree, Robert P Takes, Jatin P Shah, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 5, 2012
Molecular diagnosis of minimal residual disease in head and neck cancer patientsA Peggy Graveland, Boudewijn J M Braakhuis, Simone E J Eerenstein, et al.
NPJ Genomic Medicine|December 10, 2021
Accurate detection of circulating tumor DNA using nanopore consensus sequencingAlessio Marcozzi, Myrthe Jager, Martin Elferink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinomaPontus K E Börjesson, Ernst J Postema, Jan C Roos, et al.
Oral Oncology|July 28, 2022
Application and accuracy of ultrasound-guided resections of tongue cancerKlijs J de Koning, Robert J J van Es, Reinoud J Klijn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2009
Novel insights into pathological changes in muscular arteries of radiotherapy patientsNicola S Russell, Saske Hoving, Sylvia Heeneman, et al.
Head & Neck|August 3, 2024
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinomaAnouk W M A Schaeffers, Anouk V M Burger, Charlotte W Duinkerken, et al.
Head & Neck|November 22, 2019
The risk of second primary tumors in head and neck cancer: A systematic reviewAndrés Coca-Pelaz, Juan P Rodrigo, Carlos Suárez, et al.
Pageof 42

Showing results (321-330 of 418) with videos related to

Sort By:
Pageof 42
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancerErnst J Postema, Pontus K E Börjesson, Wilhelmina C A M Buijs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 28, 2019
Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: which groups specifically benefit? Secondary analyses of a randomized controlled trialFemke Jansen, Birgit I Lissenberg-Witte, Anna M H Krebber, et al.
Oral Oncology|March 9, 2019
Elective neck dissection in oral squamous cell carcinoma: Past, present and futureRemco de Bree, Robert P Takes, Jatin P Shah, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 5, 2012
Molecular diagnosis of minimal residual disease in head and neck cancer patientsA Peggy Graveland, Boudewijn J M Braakhuis, Simone E J Eerenstein, et al.
NPJ Genomic Medicine|December 10, 2021
Accurate detection of circulating tumor DNA using nanopore consensus sequencingAlessio Marcozzi, Myrthe Jager, Martin Elferink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinomaPontus K E Börjesson, Ernst J Postema, Jan C Roos, et al.
Oral Oncology|July 28, 2022
Application and accuracy of ultrasound-guided resections of tongue cancerKlijs J de Koning, Robert J J van Es, Reinoud J Klijn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2009
Novel insights into pathological changes in muscular arteries of radiotherapy patientsNicola S Russell, Saske Hoving, Sylvia Heeneman, et al.
Head & Neck|August 3, 2024
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinomaAnouk W M A Schaeffers, Anouk V M Burger, Charlotte W Duinkerken, et al.
Head & Neck|November 22, 2019
The risk of second primary tumors in head and neck cancer: A systematic reviewAndrés Coca-Pelaz, Juan P Rodrigo, Carlos Suárez, et al.
Pageof 42